Jordi Muchart López
Investigador
Jordi Muchart López graduated in Medicine in 2001 from the University of Barcelona and obtained his degree in Radiology in 2006.
He joined SJD Barcelona Children's Hospital as an adjunct physician in the Department of Diagnostic Imaging in 2009 where he has developed his research in the field of neuroscience in collaboration with the departments of Neuropediatrics, Neonatology, Genetics, Oncology and Neurosurgery. He is currently a consultant. Part of his research has been carried out in collaboration with CIBERER, the Cognition and Brain Plasticity Unit of IDIBELL - UB, FIDMAG and CREAL-ISGLobal.
Also, he collaborates as a lecturer in the Masters in Neuropediatrics, Child Neuropsychology, Pediatric Endocrinology and Epilepsy at the SJD Barcelona Children's Hospital -Hospital Clínic of the University of Barcelona.
Last Publications
- Slušná D, Muchart-Lopez J, Hinzen W and Canales-Rodríguez EJ White matter microstructure of language pathways in non-verbal autism: insights from diffusion tensor imaging and myelin water imaging. FRONTIERS IN HUMAN NEUROSCIENCE . 19: 1551868-1551868.
- Estévez-Arias B, Sarv S, Bonello-Palot N, Carrera-García L, Ortez-Gonzalez CI, Exposito-Escudero JM, Yubero-Siles D, Muchart-Lopez J, Delmont E, Õiglane-Shlik E, Meren T, Puusepp S, Murumets Ü, Salomons GS, Udd B, Väli L, Cantarero-Abad L, Bönnemann CG, Nascimento-Osorio A, Ramón-Maiques S, Õunap K, Hoenicka J, Natera-de Benito D and Palau F Biallelic Variants in the DARS2 Gene as a Novel Cause of Axonal Charcot-Marie-Tooth Disease ANNALS OF NEUROLOGY . : .
- Marina Caballero Bellón, Santa-María López V, Marti-Sanchez L, Martorell-Sampol L, Salinas D, Hinojosa J, Becerra MV, Pavon-Mengual M, Morales-La Madrid A, Cruz-Martínez O, Muchart-Lopez J and Salvador-Hernandez H Very early-onset symptomatic CNS haemangioblastoma in Von Hippel-Lindau disease JOURNAL OF MEDICAL GENETICS . 62(6): 409-412.
Projects
- Project name:
- TRI-VIAE: Exploración tridimensional de la epigenética en trastornos del neurodesarrollo: potencial diagnóstico, aplicabilidad en la clínica y descubrimiento de nuevas firmas epigenéticas.
- Leader
- Mercedes Serrano Gimaré
- Funding entities:
- Serrano Gimaré, Mercedes, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI24/00482
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Ensayo clínico de seguridad y factibilidad de inmunoterapia celular: Células dendríticas autólogas pulsadas con un lisado de líneas tumorales alogénicas, asociadas con CART anti-IL13Ra2 en pacientes con tumor difuso intrínseco de tronco (DIPG) (fase Ib)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI23/00063
- Starting - finishing date:
- 2024 - 2027
- Project name:
- Effectiveness, cost-utility and neurobiological effects of low-dose naltrexone in patients with fibromyalgia (INNOVA project)
- Leader
- Juan Vicente Luciano Devis
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI20/00080
- Starting - finishing date:
- 2021 - 2025